Global Paclitaxel API Market Research Report 2024

Publication ID:

PB505251466

Publication Date:

May 10, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
The global Paclitaxel API market was valued at US$ 148 million in 2023 and is anticipated to reach US$ 273.2 million by 2030, witnessing a CAGR of 9.1% during the forecast period 2024-2030.
The Paclitaxel Active Pharmaceutical Ingredient (API) market is primarily driven by its widespread use as a chemotherapy drug for various types of cancer treatment, such as breast, ovarian, and lung cancer. The increasing prevalence of cancer globally and the continuous research and development efforts to improve cancer therapies contribute to the growing demand for Paclitaxel API. Additionally, the rise in government initiatives and funding for cancer research and treatment further supports market growth. However, challenges like the complexity of the production process, regulatory hurdles, and the availability of alternatives pose obstacles to the market's expansion. Maintaining a balance between cost-effective production and maintaining quality standards remains a challenge for manufacturers in the Paclitaxel API market.
This report aims to provide a comprehensive presentation of the global market for Paclitaxel API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel API.
Report Scope
The Paclitaxel API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paclitaxel API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paclitaxel API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Segment by Type
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Segment by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Paclitaxel API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Paclitaxel API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Paclitaxel API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Paclitaxel API Market Overview
1.1 Product Definition
1.2 Paclitaxel API Segment by Type
1.2.1 Global Paclitaxel API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Natural Paclitaxel API
1.2.3 Semi-synthetic Paclitaxel API
1.3 Paclitaxel API Segment by Application
1.3.1 Global Paclitaxel API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Ovarian Cancer
1.3.3 Cervical Cancer
1.3.4 Breast Cancer
1.3.5 Other
1.4 Global Market Growth Prospects
1.4.1 Global Paclitaxel API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Paclitaxel API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Paclitaxel API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Paclitaxel API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Paclitaxel API Production Market Share by Manufacturers (2019-2024)
2.2 Global Paclitaxel API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Paclitaxel API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Paclitaxel API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Paclitaxel API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Paclitaxel API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Paclitaxel API, Product Offered and Application
2.8 Global Key Manufacturers of Paclitaxel API, Date of Enter into This Industry
2.9 Paclitaxel API Market Competitive Situation and Trends
2.9.1 Paclitaxel API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Paclitaxel API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Paclitaxel API Production by Region
3.1 Global Paclitaxel API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Paclitaxel API Production Value by Region (2019-2030)
3.2.1 Global Paclitaxel API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Paclitaxel API by Region (2025-2030)
3.3 Global Paclitaxel API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Paclitaxel API Production by Region (2019-2030)
3.4.1 Global Paclitaxel API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Paclitaxel API by Region (2025-2030)
3.5 Global Paclitaxel API Market Price Analysis by Region (2019-2024)
3.6 Global Paclitaxel API Production and Value, Year-over-Year Growth
3.6.1 North America Paclitaxel API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Paclitaxel API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Paclitaxel API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Paclitaxel API Production Value Estimates and Forecasts (2019-2030)
4 Paclitaxel API Consumption by Region
4.1 Global Paclitaxel API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Paclitaxel API Consumption by Region (2019-2030)
4.2.1 Global Paclitaxel API Consumption by Region (2019-2024)
4.2.2 Global Paclitaxel API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Paclitaxel API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Paclitaxel API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Paclitaxel API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Paclitaxel API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Paclitaxel API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Paclitaxel API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Paclitaxel API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Paclitaxel API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Paclitaxel API Production by Type (2019-2030)
5.1.1 Global Paclitaxel API Production by Type (2019-2024)
5.1.2 Global Paclitaxel API Production by Type (2025-2030)
5.1.3 Global Paclitaxel API Production Market Share by Type (2019-2030)
5.2 Global Paclitaxel API Production Value by Type (2019-2030)
5.2.1 Global Paclitaxel API Production Value by Type (2019-2024)
5.2.2 Global Paclitaxel API Production Value by Type (2025-2030)
5.2.3 Global Paclitaxel API Production Value Market Share by Type (2019-2030)
5.3 Global Paclitaxel API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Paclitaxel API Production by Application (2019-2030)
6.1.1 Global Paclitaxel API Production by Application (2019-2024)
6.1.2 Global Paclitaxel API Production by Application (2025-2030)
6.1.3 Global Paclitaxel API Production Market Share by Application (2019-2030)
6.2 Global Paclitaxel API Production Value by Application (2019-2030)
6.2.1 Global Paclitaxel API Production Value by Application (2019-2024)
6.2.2 Global Paclitaxel API Production Value by Application (2025-2030)
6.2.3 Global Paclitaxel API Production Value Market Share by Application (2019-2030)
6.3 Global Paclitaxel API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Phyton
7.1.1 Phyton Paclitaxel API Corporation Information
7.1.2 Phyton Paclitaxel API Product Portfolio
7.1.3 Phyton Paclitaxel API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Phyton Main Business and Markets Served
7.1.5 Phyton Recent Developments/Updates
7.2 ScinoPharm
7.2.1 ScinoPharm Paclitaxel API Corporation Information
7.2.2 ScinoPharm Paclitaxel API Product Portfolio
7.2.3 ScinoPharm Paclitaxel API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 ScinoPharm Main Business and Markets Served
7.2.5 ScinoPharm Recent Developments/Updates
7.3 Novasep
7.3.1 Novasep Paclitaxel API Corporation Information
7.3.2 Novasep Paclitaxel API Product Portfolio
7.3.3 Novasep Paclitaxel API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Novasep Main Business and Markets Served
7.3.5 Novasep Recent Developments/Updates
7.4 Samyang
7.4.1 Samyang Paclitaxel API Corporation Information
7.4.2 Samyang Paclitaxel API Product Portfolio
7.4.3 Samyang Paclitaxel API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Samyang Main Business and Markets Served
7.4.5 Samyang Recent Developments/Updates
7.5 Polymed
7.5.1 Polymed Paclitaxel API Corporation Information
7.5.2 Polymed Paclitaxel API Product Portfolio
7.5.3 Polymed Paclitaxel API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Polymed Main Business and Markets Served
7.5.5 Polymed Recent Developments/Updates
7.6 TAPI (Teva)
7.6.1 TAPI (Teva) Paclitaxel API Corporation Information
7.6.2 TAPI (Teva) Paclitaxel API Product Portfolio
7.6.3 TAPI (Teva) Paclitaxel API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 TAPI (Teva) Main Business and Markets Served
7.6.5 TAPI (Teva) Recent Developments/Updates
7.7 Fresenius-kabi
7.7.1 Fresenius-kabi Paclitaxel API Corporation Information
7.7.2 Fresenius-kabi Paclitaxel API Product Portfolio
7.7.3 Fresenius-kabi Paclitaxel API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Fresenius-kabi Main Business and Markets Served
7.7.5 Fresenius-kabi Recent Developments/Updates
7.8 Huiang biopharma
7.8.1 Huiang biopharma Paclitaxel API Corporation Information
7.8.2 Huiang biopharma Paclitaxel API Product Portfolio
7.8.3 Huiang biopharma Paclitaxel API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Huiang biopharma Main Business and Markets Served
7.7.5 Huiang biopharma Recent Developments/Updates
7.9 Southpharma
7.9.1 Southpharma Paclitaxel API Corporation Information
7.9.2 Southpharma Paclitaxel API Product Portfolio
7.9.3 Southpharma Paclitaxel API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Southpharma Main Business and Markets Served
7.9.5 Southpharma Recent Developments/Updates
7.10 Yunnan Hande
7.10.1 Yunnan Hande Paclitaxel API Corporation Information
7.10.2 Yunnan Hande Paclitaxel API Product Portfolio
7.10.3 Yunnan Hande Paclitaxel API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Yunnan Hande Main Business and Markets Served
7.10.5 Yunnan Hande Recent Developments/Updates
7.11 Hainan Yew Pharm
7.11.1 Hainan Yew Pharm Paclitaxel API Corporation Information
7.11.2 Hainan Yew Pharm Paclitaxel API Product Portfolio
7.11.3 Hainan Yew Pharm Paclitaxel API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Hainan Yew Pharm Main Business and Markets Served
7.11.5 Hainan Yew Pharm Recent Developments/Updates
7.12 Jiangsu Yew Biotechnology
7.12.1 Jiangsu Yew Biotechnology Paclitaxel API Corporation Information
7.12.2 Jiangsu Yew Biotechnology Paclitaxel API Product Portfolio
7.12.3 Jiangsu Yew Biotechnology Paclitaxel API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Jiangsu Yew Biotechnology Main Business and Markets Served
7.12.5 Jiangsu Yew Biotechnology Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Paclitaxel API Industry Chain Analysis
8.2 Paclitaxel API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Paclitaxel API Production Mode & Process
8.4 Paclitaxel API Sales and Marketing
8.4.1 Paclitaxel API Sales Channels
8.4.2 Paclitaxel API Distributors
8.5 Paclitaxel API Customers
9 Paclitaxel API Market Dynamics
9.1 Paclitaxel API Industry Trends
9.2 Paclitaxel API Market Drivers
9.3 Paclitaxel API Market Challenges
9.4 Paclitaxel API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂